302 related articles for article (PubMed ID: 22431923)
21. Glioblastoma cancer stem cells--from concept to clinical application.
Stopschinski BE; Beier CP; Beier D
Cancer Lett; 2013 Sep; 338(1):32-40. PubMed ID: 22668828
[TBL] [Abstract][Full Text] [Related]
22. The CD133+ tumor stem-like cell-associated antigen may elicit highly intense immune responses against human malignant glioma.
Hua W; Yao Y; Chu Y; Zhong P; Sheng X; Xiao B; Wu J; Yang B; Mao Y; Zhou L
J Neurooncol; 2011 Nov; 105(2):149-57. PubMed ID: 21479962
[TBL] [Abstract][Full Text] [Related]
23. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.
Choy W; Nagasawa DT; Trang A; Thill K; Spasic M; Yang I
Neurosurg Clin N Am; 2012 Jul; 23(3):391-405. PubMed ID: 22748652
[TBL] [Abstract][Full Text] [Related]
24. A2B5 cells from human glioblastoma have cancer stem cell properties.
Tchoghandjian A; Baeza N; Colin C; Cayre M; Metellus P; Beclin C; Ouafik L; Figarella-Branger D
Brain Pathol; 2010 Jan; 20(1):211-21. PubMed ID: 19243384
[TBL] [Abstract][Full Text] [Related]
25. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.
Joo KM; Kim SY; Jin X; Song SY; Kong DS; Lee JI; Jeon JW; Kim MH; Kang BG; Jung Y; Jin J; Hong SC; Park WY; Lee DS; Kim H; Nam DH
Lab Invest; 2008 Aug; 88(8):808-15. PubMed ID: 18560366
[TBL] [Abstract][Full Text] [Related]
26. CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.
Chiao MT; Yang YC; Cheng WY; Shen CC; Ko JL
Curr Neurovasc Res; 2011 Aug; 8(3):210-9. PubMed ID: 21675958
[TBL] [Abstract][Full Text] [Related]
27. Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem-like Cells.
McAbee JH; Rath BH; Valdez K; Young DL; Wu X; Shankavaram UT; Camphausen K; Tofilon PJ
Cancer Res; 2019 Dec; 79(23):6032-6043. PubMed ID: 31615806
[TBL] [Abstract][Full Text] [Related]
28. CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116.
Dittfeld C; Dietrich A; Peickert S; Hering S; Baumann M; Grade M; Ried T; Kunz-Schughart LA
Radiother Oncol; 2009 Sep; 92(3):353-61. PubMed ID: 19699546
[TBL] [Abstract][Full Text] [Related]
29. B7-H1 is correlated with malignancy-grade gliomas but is not expressed exclusively on tumor stem-like cells.
Yao Y; Tao R; Wang X; Wang Y; Mao Y; Zhou LF
Neuro Oncol; 2009 Dec; 11(6):757-66. PubMed ID: 19264916
[TBL] [Abstract][Full Text] [Related]
30. Cancer: stem cells and brain tumours.
Dirks PB
Nature; 2006 Dec; 444(7120):687-8. PubMed ID: 17151644
[No Abstract] [Full Text] [Related]
31. Effects of heterochromatin in colorectal cancer stem cells on radiosensitivity.
Chen T; Zhang Y; Guo WH; Meng MB; Mo XM; Lu Y
Chin J Cancer; 2010 Mar; 29(3):270-6. PubMed ID: 20193109
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro.
Wang W; Long L; Wang L; Tan C; Fei X; Chen L; Huang Q; Liang Z
Cancer Lett; 2016 Feb; 371(2):274-84. PubMed ID: 26706414
[TBL] [Abstract][Full Text] [Related]
33. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
[TBL] [Abstract][Full Text] [Related]
34. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.
Liu Q; Nguyen DH; Dong Q; Shitaku P; Chung K; Liu OY; Tso JL; Liu JY; Konkankit V; Cloughesy TF; Mischel PS; Lane TF; Liau LM; Nelson SF; Tso CL
J Neurooncol; 2009 Aug; 94(1):1-19. PubMed ID: 19468690
[TBL] [Abstract][Full Text] [Related]
35. Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells.
Lathia JD; Gallagher J; Myers JT; Li M; Vasanji A; McLendon RE; Hjelmeland AB; Huang AY; Rich JN
PLoS One; 2011; 6(9):e24807. PubMed ID: 21961046
[TBL] [Abstract][Full Text] [Related]
36. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
[TBL] [Abstract][Full Text] [Related]
37. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S
Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235
[TBL] [Abstract][Full Text] [Related]
38. Targeting brain-tumor stem cells.
Stupp R; Hegi ME
Nat Biotechnol; 2007 Feb; 25(2):193-4. PubMed ID: 17287755
[No Abstract] [Full Text] [Related]
39. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice].
Song WC; Fei XF; Dong J
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405
[TBL] [Abstract][Full Text] [Related]
40. CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma.
Piao LS; Hur W; Kim TK; Hong SW; Kim SW; Choi JE; Sung PS; Song MJ; Lee BC; Hwang D; Yoon SK
Cancer Lett; 2012 Feb; 315(2):129-37. PubMed ID: 22079466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]